Literature DB >> 19763133

Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study.

Hisatomi Arima1, Koji Yonemoto, Yasufumi Doi, Toshiharu Ninomiya, Jun Hata, Yumihiro Tanizaki, Masayo Fukuhara, Kiyoshi Matsumura, Mitsuo Iida, Yutaka Kiyohara.   

Abstract

The objective of this paper is to develop a new risk prediction model of cardiovascular disease and to validate its performance in a general population of Japanese. The Hisayama study is a population-based prospective cohort study. A total of 2634 participants aged 40 years or older were followed up for 14 years for incident cardiovascular disease (stroke and coronary heart disease (myocardial infarction, coronary revascularization and sudden cardiac death)). We used data among a random two-thirds (the derivation cohort, n=1756) to develop a new risk prediction model that was then tested to compare observed and predicted outcomes in the remaining one-third (the validation cohort, n=878). A multivariable cardiovascular risk prediction model was developed that incorporated age, sex, systolic blood pressure, diabetes, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and smoking. We assessed the performance of the model for predicting individual cardiovascular event among the validation cohort. The risk prediction model demonstrated good discrimination (c-statistic=0.81; 95% confidence interval, 0.77 to 0.86) and calibration (Hosmer-Lemeshow chi(2)-statistic=6.46; P=0.60). A simple risk score sheet based on the cardiovascular risk prediction model was also presented. We developed and validated a new cardiovascular risk prediction model in a general population of Japanese. The risk prediction model would provide a useful guide to estimate absolute risk of cardiovascular disease and to treat individual risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19763133     DOI: 10.1038/hr.2009.161

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  11 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 2.  Clinical studies on pharmacological treatment of hypertension in Japan.

Authors:  Kazuomi Kario; Satoshi Hoshide; Koichi Yamamoto; Ayako Okura; Hiromi Rakugi
Journal:  J Hum Hypertens       Date:  2021-05-07       Impact factor: 3.012

3.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

4.  Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores.

Authors:  Daisuke Manita; Hiroshi Yoshida; Yuji Hirowatari
Journal:  J Atheroscler Thromb       Date:  2016-12-26       Impact factor: 4.928

Review 5.  Atherosclerotic Cardiovascular Risk in Japan.

Authors:  Shuko Nojiri; Hiroyuki Daida
Journal:  Jpn Clin Med       Date:  2017-06-19

6.  Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project.

Authors:  Jun Hata; Akiko Nagai; Makoto Hirata; Yoichiro Kamatani; Akiko Tamakoshi; Zentaro Yamagata; Kaori Muto; Koichi Matsuda; Michiaki Kubo; Yusuke Nakamura; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  J Epidemiol       Date:  2016-12-27       Impact factor: 3.211

7.  New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population.

Authors:  Hiroyuki Hirai; Koichi Asahi; Satoshi Yamaguchi; Hirotaka Mori; Hiroaki Satoh; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Shouichi Fujimoto; Ichiei Narita; Tsuneo Konta; Masahide Kondo; Yugo Shibagaki; Masato Kasahara; Tsuyoshi Watanabe; Michio Shimabukuro
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

8.  Cardiovascular risk assessment tools in Asia.

Authors:  Yuqing Zhang; Huanhuan Miao; Yook-Chin Chia; Peera Buranakitjaroen; Saulat Siddique; Jinho Shin; Yuda Turana; Sungha Park; Kelvin Tsoi; Chen-Huan Chen; Hao-Min Cheng; Yan Li; Huynh Van Minh; Michiaki Nagai; Jennifer Nailes; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Narsingh Verma; Tzung-Dau Wang; Satoshi Hoshide; Kazuomi Kario; Jiguang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-01-04       Impact factor: 3.738

Review 9.  Innovatively Established Analysis Method for Lipoprotein Profiles Based on High-Performance Anion-Exchange Liquid Chromatography.

Authors:  Yuji Hirowatari; Hiroshi Yoshida
Journal:  J Atheroscler Thromb       Date:  2019-09-20       Impact factor: 4.928

10.  Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.

Authors:  Takanori Honda; Sanmei Chen; Jun Hata; Daigo Yoshida; Yoichiro Hirakawa; Yoshihiko Furuta; Mao Shibata; Satoko Sakata; Takanari Kitazono; Toshiharu Ninomiya
Journal:  J Atheroscler Thromb       Date:  2021-01-22       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.